Role of the mutations Trp(8)double right arrow Arg and Ile(15)double rightarrow Thr of the human luteinizing hormone beta-subunit in women with polycystic ovary syndrome

Objective: To evaluate the clinical significance of LH in the form of a mut ant beta-subunit in women with polycystic ovary syndrome (PCOS). Design: Prospective, controlled study. Setting: University hospital. Patient(s): Thirty healthy women and 30 women with PCOS. Intervention(s): Clinical, ultrasonographic, and hormonal findings were use d to define PCOS. Nucleotide mutations within codons 8 and 15 in the LH bet a-subunit gene (Trp(8) double right arrow Arg and Ile(15) double right arro w Thr) were analyzed with the use of polymerase chain reaction and subseque nt restriction fragment length polymorphism. Main Outcome Measure(s:): Serum levels of gonadotropins, androgens, E-2, an d prolactin were determined, and the results of restriction fragment length polymorphism were analyzed. Result(s): Five women in the control group and one woman in the PCOS group were found to be affected by the LH beta gene mutations. No difference was observed in serum androgen and E-2 levels between the affected women and 25 healthy women who were homozygous for the wild-type LH. However, women who se serum LH levels were less than or equal to 5.1 mIU/mL had a higher risk of having mutant LH. Conclusion(s): The frequency of LH mutations in women with PCOS is similar to that in healthy women. The presence of the variant does not cause any si gnificant change in serum levels of androgens and E-2. (Fertil Steril(R) 19 99;71:425-30. (C)1999 by American Society for Reproductive Medicine.).